DK0950050T3 - Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms - Google Patents

Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms

Info

Publication number
DK0950050T3
DK0950050T3 DK97952986T DK97952986T DK0950050T3 DK 0950050 T3 DK0950050 T3 DK 0950050T3 DK 97952986 T DK97952986 T DK 97952986T DK 97952986 T DK97952986 T DK 97952986T DK 0950050 T3 DK0950050 T3 DK 0950050T3
Authority
DK
Denmark
Prior art keywords
crystallizing
crystalline forms
resulting crystalline
tetrahydropyridine derivative
tetrahydropyridine
Prior art date
Application number
DK97952986T
Other languages
Danish (da)
Inventor
Antoine Caron
Bruno Franc
Olivier Monnier
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK0950050T3 publication Critical patent/DK0950050T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97952986T 1996-12-23 1997-12-23 Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms DK0950050T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615904A FR2757543B1 (en) 1996-12-23 1996-12-23 PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED

Publications (1)

Publication Number Publication Date
DK0950050T3 true DK0950050T3 (en) 2006-01-23

Family

ID=9499043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97952986T DK0950050T3 (en) 1996-12-23 1997-12-23 Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms

Country Status (39)

Country Link
EP (1) EP0950050B1 (en)
JP (2) JP4499188B2 (en)
KR (1) KR100586670B1 (en)
CN (1) CN1129580C (en)
AR (1) AR009672A1 (en)
AT (1) ATE307802T1 (en)
AU (1) AU736697B2 (en)
BR (1) BR9714081A (en)
CA (1) CA2275596C (en)
CO (1) CO5070688A1 (en)
CZ (1) CZ296689B6 (en)
DE (1) DE69734460T2 (en)
DK (1) DK0950050T3 (en)
DZ (1) DZ2383A1 (en)
EE (1) EE04188B1 (en)
EG (1) EG21567A (en)
ES (1) ES2251038T3 (en)
FR (1) FR2757543B1 (en)
HK (1) HK1024002A1 (en)
HR (1) HRP970699B1 (en)
HU (1) HU227425B1 (en)
IL (1) IL129938A (en)
IN (1) IN186976B (en)
IS (1) IS2357B (en)
MY (1) MY118015A (en)
NO (1) NO312364B1 (en)
NZ (1) NZ336130A (en)
PL (1) PL190494B1 (en)
RS (1) RS49882B (en)
RU (1) RU2192416C2 (en)
SA (1) SA98180971B1 (en)
SI (1) SI0950050T1 (en)
SK (1) SK285088B6 (en)
TR (1) TR199901363T2 (en)
TW (1) TW518322B (en)
UA (1) UA60324C2 (en)
UY (1) UY24825A1 (en)
WO (1) WO1998028271A1 (en)
ZA (1) ZA9711576B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (en) * 1996-12-23 1999-04-02 Sanofi Sa PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED
FR2782082B3 (en) * 1998-08-05 2000-09-22 Sanofi Sa CRYSTALLINE FORMS OF (R) - (+) - N - [[3- [1-BENZOYL-3- (3,4- DICHLOROPHENYL) PIPERIDIN-3-YL] PROP-1-YL] -4-PHENYLPIPERIDIN-4 - YL] -N-METHYLACETAMIDE (OSANETANT) AND PROCESS FOR THE PREPARATION OF SAID COMPOUND
US9272068B2 (en) 2010-03-12 2016-03-01 Nippon Shokubai Co., Ltd. Process for producing water-absorbing resin
AP2013006779A0 (en) * 2011-04-15 2013-03-31 Emcure Pharmaceuticals Ltd An improved rilpivirine process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (en) * 1982-08-16 1984-02-17 Midy Spa SUBSTITUTED TRIFLUOROMETHYLPHENYLTETRAHYDROPYRIDINES WITH ANOREXIGENIC ACTIVITY, A PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS
FR2757543B1 (en) * 1996-12-23 1999-04-02 Sanofi Sa PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED

Also Published As

Publication number Publication date
CZ296689B6 (en) 2006-05-17
EE9900264A (en) 2000-02-15
CO5070688A1 (en) 2001-08-28
AU5668498A (en) 1998-07-17
DE69734460T2 (en) 2006-07-06
RS49882B (en) 2008-08-07
HRP970699B1 (en) 2007-03-31
YU28999A (en) 2003-01-31
FR2757543B1 (en) 1999-04-02
IS2357B (en) 2008-04-15
JP2001507012A (en) 2001-05-29
EE04188B1 (en) 2003-12-15
TW518322B (en) 2003-01-21
IS5076A (en) 1999-06-10
PL190494B1 (en) 2005-12-30
CN1241180A (en) 2000-01-12
NO993076D0 (en) 1999-06-22
KR20000069504A (en) 2000-11-25
TR199901363T2 (en) 1999-08-23
NZ336130A (en) 2001-01-26
SK82899A3 (en) 1999-12-10
SI0950050T1 (en) 2006-04-30
FR2757543A1 (en) 1998-06-26
UA60324C2 (en) 2003-10-15
EG21567A (en) 2001-12-31
AR009672A1 (en) 2000-04-26
BR9714081A (en) 2000-05-09
DE69734460D1 (en) 2005-12-01
HUP0001387A3 (en) 2002-03-28
CN1129580C (en) 2003-12-03
CZ229299A3 (en) 1999-09-15
ZA9711576B (en) 1998-06-25
HRP970699A2 (en) 1998-10-31
SK285088B6 (en) 2006-06-01
AU736697B2 (en) 2001-08-02
NO993076L (en) 1999-06-22
SA98180971B1 (en) 2006-09-13
HU227425B1 (en) 2011-05-30
EP0950050B1 (en) 2005-10-26
MY118015A (en) 2004-08-30
IL129938A0 (en) 2000-02-29
CA2275596A1 (en) 1998-07-02
PL334256A1 (en) 2000-02-14
JP4499188B2 (en) 2010-07-07
KR100586670B1 (en) 2006-06-07
IN186976B (en) 2001-12-22
IL129938A (en) 2004-06-20
NO312364B1 (en) 2002-04-29
EP0950050A1 (en) 1999-10-20
DZ2383A1 (en) 2002-12-28
WO1998028271A1 (en) 1998-07-02
CA2275596C (en) 2005-10-11
RU2192416C2 (en) 2002-11-10
HUP0001387A2 (en) 2000-09-28
ES2251038T3 (en) 2006-04-16
HK1024002A1 (en) 2000-09-29
ATE307802T1 (en) 2005-11-15
UY24825A1 (en) 1998-04-21
JP2009197022A (en) 2009-09-03

Similar Documents

Publication Publication Date Title
DK0973796T3 (en) Process for preparing and purifying an N-alkylated aspartame derivative
DK0845956T4 (en) Process for making a toothbrush
DK0740052T3 (en) Method and plant for implementing a thermodynamic cycle
NO993006L (en) A process for separating the paraxyl comprising an adsorption step with water injection and a crystallization step
DK121796A (en) Method and plant for removing a superstructure
DK139093A (en) Refrigeration plant and method for controlling a refrigeration plant
DE69620107D1 (en) crystallization process
EE9600153A (en) Method for obtaining nicotinic acid amide
DK0946312T3 (en) Process for automated process control of a straightening process
DK0900253T3 (en) Bitumen compositions and a process for their preparation
NO995909L (en) Crystalline macrolides and process for their preparation
DK0734382T3 (en) Crystalline N-acetyl-neuramic acid derivatives and methods for their preparation
DK0625586T3 (en) Structural element and method for making this
DK0711774T3 (en) New crystalline cephemic acid addition salts and processes for their preparation
DK0950050T3 (en) Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms
FI971675A0 (en) A method for inhibiting bradykinin-related conditions
MD254B1 (en) Apple cultivation process
DK0789700T3 (en) Improved process for preparing a D - (+) - biotin intermediate
DK0677265T3 (en) Device and method for controlling a cooker
DK153497A (en) Process for manufacturing roofing elements and means for carrying out the method
FI961942A (en) Method for inerting waste by crystallization
DK0638243T3 (en) Process for making bean puree
MD940028A (en) Process for obtaining crystalline tylosin
DK0686964T3 (en) Method and system for producing a synthesized analog signal
DK7494A (en) Ground fastening structure and method for making a ground fastening structure